Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/171056
Title: SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1α-LIPIN 1 pathway and increasing CD36 through Nrf2
Author: Barroso Fernández, Emma
Rodríguez-Rodríguez, Rosalia
Zarei, Mohammad
Pizarro Delgado, Javier
Planavila Porta, Ana
Palomer Tarridas, Francesc Xavier
Villarroya i Gombau, Francesc
Vázquez Carrera, Manuel
Keywords: Malalties del fetge
Lípids
Liver diseases
Lipids
Issue Date: 10-Sep-2020
Publisher: BioMed Central
Abstract: Background: Deficiency of mitochondrial sirtuin 3 (SIRT3), a NAD+ -dependent protein deacetylase that maintains redox status and lipid homeostasis, contributes to hepatic steatosis. In this study, we investigated additional mechanisms that might play a role in aggravating hepatic steatosis in Sirt3-deficient mice fed a high-fat diet (HFD). Methods: Studies were conducted in wild-type (WT) and Sirt3−/− mice fed a standard diet or a HFD and in SIRT3- knockdown human Huh-7 hepatoma cells. Results: Sirt3−/− mice fed a HFD presented exacerbated hepatic steatosis that was accompanied by decreased expression and DNA-binding activity of peroxisome proliferator-activated receptor (PPAR) α and of several of its target genes involved in fatty acid oxidation, compared to WT mice fed the HFD. Interestingly, Sirt3 deficiency in liver and its knockdown in Huh-7 cells resulted in upregulation of the nuclear levels of LIPIN1, a PPARα co-activator, and of the protein that controls its levels and localization, hypoxia-inducible factor 1α (HIF-1α). These changes were prevented by lipid exposure through a mechanism that might involve a decrease in succinate levels. Finally, Sirt3−/− mice fed the HFD showed increased levels of some proteins involved in lipid uptake, such as CD36 and the VLDL receptor. The upregulation in CD36 was confirmed in Huh-7 cells treated with a SIRT3 inhibitor or transfected with SIRT3 siRNA and incubated with palmitate, an effect that was prevented by the Nrf2 inhibitor ML385. Conclusion: These findings demonstrate new mechanisms by which Sirt3 deficiency contributes to hepatic steatosis
Note: Reproducció del document publicat a: https://doi.org/10.1186/s12964-020-00640-8
It is part of: Cell Communication and Signaling, 2020, vol. 18, num. 147
URI: http://hdl.handle.net/2445/171056
Related resource: https://doi.org/10.1186/s12964-020-00640-8
ISSN: 1478-811X
Appears in Collections:Articles publicats en revistes (Institut de Biomedicina (IBUB))
Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)

Files in This Item:
File Description SizeFormat 
703469.pdf2.68 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons